The company is in serious trouble. Founder John Abele has left and CEO Ray Elliott is leaving. Boston Scientific's debt refinancing is cratering (who wants to lend them money?) and another big round of job cuts is coming in June. The neuromodulation division in California, which is being prepped for sale, is not going to be spared. The buildings are available for sublease if you dig around.
There are no replies in this thread yet. Be the first to post a reply below: